Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform